QS Investors’s AngioDynamics ANGO Stock Holding History

QS Investors’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-36,020	Closed	-$726K	–	1649
2018 Q4	$726K	Hold	36,020	–	–	0.01%	838
2018 Q3	$783K	Sell	36,020 -370	-1%	-$8.22K	0.01%	867
2018 Q2	$809K	Hold	36,390	–	–	0.01%	836
2018 Q1	$628K	Sell	36,390 -2,962	-8%	-$49.4K	0.01%	881
2017 Q4	$654K	Sell	39,352 -2,999	-7%	-$51.2K	0.01%	879
2017 Q3	$724K	Hold	42,351	–	–	0.01%	862
2017 Q2	$687K	Buy	42,351 +11,504	+37%	+$182K	0.01%	848
2017 Q1	$535K	Buy	+30,847	New	+$516K	﹤0.01%	949
2015 Q2	–	Sell	-102,533	Closed	-$1.82M	–	1407
2015 Q1	$1.82M	Sell	102,533 -58,748	-36%	-$1.09M	0.02%	613
2014 Q4	$3.07M	Buy	+161,281	New	+$2.73M	0.04%	491

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

QS Investors's ANGO Position: Q1 2019 in Review

QS Investors sold out of AngioDynamics (ANGO) in Q1 2019, closing a stake of 36,020 shares — an estimated $726K sold.

QS Investors first reported a position in ANGO in Q4 2014 and held it in 10 quarters. The position peaked at $3.07M in Q4 2014. 179 funds tracked by Wall St. Rank hold ANGO as of Q1 2019.

QS Investors reported no remaining AngioDynamics position as of Q1 2019 after selling out during the quarter.
QS Investors sold 36,020 AngioDynamics shares in Q1 2019, an estimated $726K.
QS Investors first reported a position in AngioDynamics in Q4 2014 and held it in 10 quarters.
QS Investors's AngioDynamics position peaked at $3.07M in Q4 2014.
179 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2019.

Based on QS Investors's 13F filing for Q1 2019, filed 15 May 2019.